Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 13/20 | 1.00 |
| ▸ | P2RY6 | Q15077 | 8/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 7/20 | 1.00 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine Diphosphate Glucose SCHEMBL12646851 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL12377960 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL1521203 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL454078 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL12133202 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL1520993 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL24747518 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL4972812 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL12016940 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL20680471 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6131 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146271-A1 | UDP-SUGAR BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2026-05-28 | — | — | US | claimed |
| EP-3620510-B2 | FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES BY TOTAL FERMENTATION UTILIZING A MIXED FEEDSTOCK | CHR HANSEN HMO GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| CN-122038335-A | Beta1, 4-galactosyltransferase Habeta 4GalT-I211V and application thereof in synthesis pLNnH | 中国海洋大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122038339-A | Glycosyltransferase IlUGT A3 and application thereof in flavonoid glycoside synthesis | 国际竹藤中心 | 2026-05-15 | — | — | CN | claimed |
| US-12618091-B2 | Production of human milk oligosaccharides in microbial hosts with engineered import/export | CHR. HANSEN A/S (DK) | 2026-05-05 | — | — | US | claimed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | claimed |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| EP-4702042-A1 | SIALYLATED HUMAN FACTOR H PROTEIN AND THERAPEUTIC USE THEREOF | eleva GmbH (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| US-12553073-B2 | Galactose to tagatose isomerization at moderate temperatures with high conversion and productivity | TRUSTEES OF TUFTS COLLEGE (US) | 2026-02-17 | — | — | US | claimed |
| US-5618705-A | REACTING DISACCHARIDE COMPRISING LAMINARIBOSE, GENTIOBIOSE, AND MALTOSE WITH GALACTOSE IN THE PRESENCE OF LACTALBUMIN | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY MECHANICAL COLLEGE (US) | 1997-04-08 | — | — | US | claimed |
| EP-0754057-A1 | COMPOSITIONS AND METHODS FOR VACCINES COMPRISING $g(a)-GALACTOSYL EPITOPES | MEDICAL COLLEGE OF PENNSYLVANIA AND HAHNEMANN UNIVERSITY (US) | 1997-01-22 | — | — | EP | claimed |
| WO-1996032491-A1 | ENZYMATIC SYNTHESIS OF GLYCOSIDIC LINKAGES | CYTEL CORPORATION (US) | 1996-10-17 | — | — | WO | claimed |
| WO-1995024924-A1 | COMPOSITIONS AND METHODS FOR VACCINES COMPRISING α-GALACTOSYL EPITOPES | MEDICAL COLLEGE OF PENNSYLVANIA AND HAHNEMANN UNIVERSITY (US) | 1995-09-21 | — | — | WO | claimed |
| US-5432059-A | Assay for glycosylation deficiency disorders | SPECIALTY LABORATORIES, INC. (US) | 1995-07-11 | — | — | US | claimed |
| US-5426178-A | Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1995-06-20 | — | — | US | claimed |
| EP-0359347-B1 | COVALENTLY-LINKED COMPLEXES AND METHODS FOR ENHANCED CYTOTOXICITY AND IMAGING | NEORX CORPORATION (US) | 1992-12-23 | — | — | EP | claimed |
| WO-1990007000-A2 | NUCLEOTIDES ENCODING HUMAN B1, 4-GALACTOSYLTRANSFERASE AND USES THEREOF | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1990-06-28 | — | — | WO | claimed |
| EP-0134292-B1 | DETERMINATION OF CARBOHYDRATE ACCEPTORS | ABBOTT LABORATORIES (US) | 1989-08-23 | — | — | EP | claimed |
| EP-0134292-A1 | Determination of carbohydrate acceptors | ABBOTT LABORATORIES (US) | 1985-03-20 | — | — | EP | claimed |